Michael Privitera

14.7k total citations · 3 hit papers
168 papers, 7.7k citations indexed

About

Michael Privitera is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cognitive Neuroscience. According to data from OpenAlex, Michael Privitera has authored 168 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Psychiatry and Mental health, 82 papers in Pediatrics, Perinatology and Child Health and 48 papers in Cognitive Neuroscience. Recurrent topics in Michael Privitera's work include Epilepsy research and treatment (118 papers), Pharmacological Effects and Toxicity Studies (67 papers) and Neuroscience and Neuropharmacology Research (32 papers). Michael Privitera is often cited by papers focused on Epilepsy research and treatment (118 papers), Pharmacological Effects and Toxicity Studies (67 papers) and Neuroscience and Neuropharmacology Research (32 papers). Michael Privitera collaborates with scholars based in United States, United Kingdom and Spain. Michael Privitera's co-authors include Jerzy P. Szaflarski, Hwa‐Shain Yeh, Andrés M. Kanner, Gus A. Baker, Kimford J. Meador, Jill Clayton‐Smith, David W. Loring, Joyce Liporace, Laura A. Kalayjian and Page B. Pennell and has published in prestigious journals such as New England Journal of Medicine, Brain and Neurology.

In The Last Decade

Michael Privitera

161 papers receiving 7.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

2018 661 citations Michael Privitera et al. profile →
Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs

2009 515 citations Kimford J. Meador, Gus A. Baker et al. profile →
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

2013 513 citations Kimford J. Meador, Gus A. Baker et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael Privitera	5.3k	3.8k	1.5k	1.5k	1.1k	168	7.7k
Cynthia L. Harden	4.2k 0.8×	2.9k 0.8×	984 0.6×	1.5k 1.0×	678 0.6×	161	6.3k
David Gloss	3.6k 0.7×	1.6k 0.4×	1.4k 0.9×	1.4k 0.9×	262 0.2×	57	6.5k
Andrés M. Kanner	11.7k 2.2×	8.0k 2.1×	2.2k 1.5×	3.5k 2.4×	1.3k 1.1×	256	14.6k
Marco Mula	5.4k 1.0×	3.4k 0.9×	1.0k 0.7×	1.6k 1.1×	164 0.2×	183	6.9k
Page B. Pennell	4.2k 0.8×	4.8k 1.2×	1.2k 0.8×	852 0.6×	3.3k 3.1×	157	7.5k
Ilo E. Leppik	6.6k 1.2×	5.9k 1.5×	550 0.4×	2.3k 1.5×	327 0.3×	249	8.8k
Richard H. Mattson	7.8k 1.5×	5.2k 1.4×	2.1k 1.4×	3.9k 2.7×	305 0.3×	153	11.1k
Vilho V. Myllylä	3.1k 0.6×	2.1k 0.6×	1.1k 0.8×	686 0.5×	697 0.6×	149	7.9k
Frank Gilliam	8.2k 1.5×	5.3k 1.4×	2.1k 1.3×	2.9k 1.9×	161 0.1×	159	10.2k
Elinor Ben‐Menachem	6.1k 1.2×	5.0k 1.3×	1.4k 0.9×	3.3k 2.2×	224 0.2×	149	9.2k

Countries citing papers authored by Michael Privitera

Since Specialization

Citations

This map shows the geographic impact of Michael Privitera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Privitera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Privitera more than expected).

Fields of papers citing papers by Michael Privitera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Privitera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Privitera. The network helps show where Michael Privitera may publish in the future.

Co-authorship network of co-authors of Michael Privitera

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Privitera. A scholar is included among the top collaborators of Michael Privitera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Privitera. Michael Privitera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aboumatar, Sami, Jay R. Gavvala, Zeenat Jaisani, et al.. (2025). Electrographic seizures on responsive neurostimulation: An early and objective measure of response to cenobamate. Epilepsy Research. 218. 107647–107647. 1 indexed citations

Privitera, Michael, Lucy Mendoza, Enrique Carrazana, & Adrián L. Rabinowicz. (2023). Intracerebral electrographic activity following a single dose of diazepam nasal spray: A pilot study. Epilepsia Open. 9(1). 380–387. 2 indexed citations

Welty, Timothy E., Barry E. Gidal, Michael Privitera, et al.. (2021). Coffee and cigarette smoking interactions with lamotrigine. Epilepsy & Behavior. 116. 107741–107741. 4 indexed citations

Foreman, Brandon, Jed A. Hartings, Laura B. Ngwenya, et al.. (2021). Seizures and Cognitive Outcome After Traumatic Brain Injury: A Post Hoc Analysis. Neurocritical Care. 36(1). 130–138. 9 indexed citations

Kim, Kwang Ki, Michael Privitera, & Jerzy P. Szaflarski. (2011). Lessons learned from a comparison of language localisation using fMRI and electrocortical mapping: case studies of neocortical epilepsy patients. Epileptic Disorders. 13(4). 368–374. 3 indexed citations

Meador, Kimford J., Gus A. Baker, N. Andrew Browning, et al.. (2009). Cognitive Function at Three Years of Age After Fetal Exposure to Antiepileptic Drugs. Obstetrical & Gynecological Survey. 64(8). 517–518.

Vannest, Jennifer, Jerzy P. Szaflarski, Michael Privitera, Bruce K. Schefft, & Scott K. Holland. (2008). Medial temporal fMRI activation reflects memory lateralization and memory performance in patients with epilepsy. Epilepsy & Behavior. 12(3). 410–418. 49 indexed citations

Testa, S. Marc, Bruce K. Schefft, Jerzy P. Szaflarski, Hwa‐Shain Yeh, & Michael Privitera. (2007). Mood, Personality, and Health‐related Quality of Life in Epileptic and Psychogenic Seizure Disorders. Epilepsia. 48(5). 973–982. 65 indexed citations

Goldberg‐Stern, Hadassa, Natan Gadoth, David M. Ficker, & Michael Privitera. (2004). The effect of age and structural lesions on postictal language impairment. Seizure. 14(1). 62–65. 6 indexed citations

10.

Cavitt, Jennifer & Michael Privitera. (2004). Levetiracetam Induces a Rapid and Sustained Reduction of Generalized Spike-Wave and Clinical Absence. Archives of Neurology. 61(10). 1604–1604. 25 indexed citations

11.

Dulay, Mario F., Bruce K. Schefft, Jamison D. Fargo, Michael Privitera, & Hwa‐Shain Yeh. (2004). Severity of depressive symptoms, hippocampal sclerosis, auditory memory, and side of seizure focus in temporal lobe epilepsy. Epilepsy & Behavior. 5(4). 522–531. 36 indexed citations

12.

Tang, Yang, Aigang Lu, Ruiqiong Ran, et al.. (2004). Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1. Molecular Brain Research. 132(2). 155–167. 39 indexed citations

13.

Abou‐Khalil, Bassel, et al.. (2003). An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day−1 in adult patients with refractory epilepsy. Seizure. 12(3). 141–149. 37 indexed citations

14.

Schefft, Bruce K., S. Marc Testa, Mario F. Dulay, Michael Privitera, & Hwa‐Shain Yeh. (2003). Preoperative assessment of confrontation naming ability and interictal paraphasia production in unilateral temporal lobe epilepsy. Epilepsy & Behavior. 4(2). 161–168. 35 indexed citations

15.

Privitera, Michael, et al.. (2001). Levetiracetam add-on for drug-resistant localization related (partial) epilepsy. Cochrane Database of Systematic Reviews. CD001901–CD001901. 35 indexed citations

16.

Privitera, Michael. (1999). Evidence‐based Medicine and Antiepileptic Drugs. Epilepsia. 40(s5). S47–56. 20 indexed citations

17.

Rosenfeld, William E., Rǎjesh C. Sachdeo, Edward Faught, & Michael Privitera. (1997). Long‐Term Experience with Topiramate as Adjunctive Therapy and as Monotherapy in Patients with Partial Onset Seizures: Retrospective Survey of Open‐Label Treatment. Epilepsia. 38(s1). S34–6. 46 indexed citations

18.

Privitera, Michael, Richard W. Fincham, J. K. Penry, et al.. (1996). Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Neurology. 46(6). 1678–1683. 286 indexed citations

19.

Jooma, Rashid, et al.. (1995). Seizure control and extent of mesial temporal resection. Acta Neurochirurgica. 133(1-2). 44–49. 31 indexed citations

20.

Jooma, Rashid, Hwa‐Shain Yeh, Michael Privitera, & Maureen Gartner. (1995). Lesionectomy versus electrophysiologically guided resection for temporal lobe tumors manifesting with complex partial seizures. Journal of neurosurgery. 83(2). 231–236. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact